Fluoxetine
10 mg · Tablet, Film Coated
- Prescription only
- Serotonin Reuptake Inhibitor
- Active substance
- Fluoxetine
- Made by
- REMEDYREPACK INC.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
This information is not included in the verified source. Open the official leaflet
How it works
From the US prescribing label for the same active substance (FLUOXETINE). It describes the substance, not this exact product.
Although the exact mechanism of fluoxetine is unknown, it is presumed to be linked to its inhibition of CNS neuronal uptake of serotonin.
Metabolism - Fluoxetine is extensively metabolized in the liver to norfluoxetine and a number of other unidentified metabolites.
The primary route of elimination appears to be hepatic metabolism to inactive metabolites excreted by the kidney.
Food does not appear to affect the systemic bioavailability of fluoxetine, although it may delay its absorption by 1 to 2 hours, which is probably not clinically significant.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-08-11
Safety of the active substance
From the US prescribing label for the same active substance (FLUOXETINE). It describes the substance, not this exact product.
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS.
- When using fluoxetine and olanzapine in combination, also refer to the Contraindications section of the package insert for Symbyax.
- Serotonin Syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders with fluoxetine or within 5 weeks of stopping treatment with fluoxetine.
- Do not use fluoxetine within 14 days of stopping an MAOI intended to treat psychiatric disorders.
- In addition, do not start fluoxetine in a patient who is being treated with linezolid or intravenous methylene blue ( 4.1 ) Pimozide: Do not use.
The most common adverse reaction (incidence at least 1% for fluoxetine and greater than placebo) associated with discontinuation in 3 pediatric placebo-controlled trials (N=418 randomized; 228 fluoxetine-treated; 190 placebo-treated) was mania/hypomania (1.8% for fluoxetine-treated, 0% for placebo-treated).
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Details
| Made by | REMEDYREPACK INC. |
|---|---|
| Active substance | Fluoxetine |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 10 mg |
| Form | Tablet, Film Coated |
| Route | Oral |
| Packs | 30 TABLET, FILM COATED in 1 BLISTER PACK |
| NDC | 70518-4429 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
127 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Capsule97 products
- Tablet, Film Coated16 products
10 mg7
10 mg · 7 companies
60 mg3
60 mg · 3 companies
- Tablet7 products
10 mg2
10 mg · 2 companies
20 mg3
60 mg2
60 mg · 2 companies
- Solution4 products
20 mg/5mL4
Show all forms · 5 forms
- Liquid3 products
20 mg/5mL3
20 mg/5mL · 3 companies
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.